Pfizer Declares Second-Quarter 2024 Dividend
April 24 2024 - 4:37PM
Business Wire
Board of Directors approves quarterly
cash dividend of $0.42 per share
Pfizer Inc. (NYSE: PFE) today announced that its board of
directors declared a $0.42 second-quarter 2024 dividend on the
company’s common stock, payable June 14, 2024, to holders of the
Common Stock of record at the close of business on May 10, 2024.
The second-quarter 2024 cash dividend will be the 342nd consecutive
quarterly dividend paid by Pfizer.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
175 years, we have worked to make a difference for all who rely on
us. We routinely post information that may be important to
investors on our website at www.Pfizer.com. In addition, to learn
more, please visit us on www.Pfizer.com and follow us on X at
@Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook
at Facebook.com/Pfizer.
Category: Corporate, Finance
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240424881798/en/
Media:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor:
IR@Pfizer.com
+1 (212) 733-4848
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024